Results 31 to 40 of about 120 (102)

Advanced Hybrid System for Ammonium Valorization as Liquid Fertilizer from Treated Urban Wastewaters: Validation of Natural Zeolites Pretreatment and Liquid-Liquid Membrane Contactors at Pilot Plant Scale. [PDF]

Membranes (Basel), 2023
Mayor Á, Reig M, Vecino X, Cortina JL, Valderrama C.   +4 more
europepmc   +1 more source

The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy. [PDF]

Front Pharmacol, 2021
Xoxi E, Facey KM, Cicchetti A.
europepmc   +1 more source

Response Surface Modeling and Optimization of the Extraction of Phenolic Antioxidants from Olive Mill Pomace. [PDF]

Molecules, 2022
Paulo F, Tavares L, Santos L.
europepmc   +1 more source

A Method for Predicting Production Costs Based on Data Fusion from Multiple Sources for Industry 4.0: Trends and Applications of Machine Learning Methods. [PDF]

Comput Intell Neurosci, 2023
Soleimani M, Naderian H, Afshinfar AH, Savari Z, Tizhari M, Agha Seyed Hosseini SR.   +5 more
europepmc   +1 more source

Advances and Applications of Hollow Fiber Nanofiltration Membranes: A Review. [PDF]

Membranes (Basel), 2021
Sewerin T, Elshof MG, Matencio S, Boerrigter M, Yu J, de Grooth J.   +5 more
europepmc   +1 more source

Riding the wave of innovation: immunoinformatics in fish disease control. [PDF]

PeerJ, 2023
Razali SA, Shamsir MS, Ishak NF, Low CF, Azemin WA.   +4 more
europepmc   +1 more source

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network. [PDF]

Orphanet J Rare Dis, 2020
Heard JM, Vrinten C, Schlander M, Bellettato CM, van Lingen C, Scarpa M, MetabERN collaboration group.   +6 more
europepmc   +1 more source

Augmenting the Standard Operating Procedures of Health and Air Quality Stakeholders With NASA Resources. [PDF]

Geohealth, 2021
Duncan BN, Malings CA, Knowland KE, Anderson DC, Prados AI, Keller CA, Cromar KR, Pawson S, Ensz H.   +8 more
europepmc   +1 more source

Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases. [PDF]

Appl Health Econ Health Policy
Hosseini F, Mobinizadeh M, Padula WV.
europepmc   +1 more source

Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed? [PDF]

Biomed Hub, 2020
Horgan D, Moss B, Boccia S, Genuardi M, Gajewski M, Capurso G, Fenaux P, Gulbis B, Pellegrini M, Mañú Pereira MDM, Gutiérrez Valle V, Gutiérrez Ibarluzea I, Kent A, Cattaneo I, Jagielska B, Belina I, Tumiene B, Ward A, Papaluca M.   +18 more
europepmc   +1 more source